Trial intelligence / Profile preview

Yuhudie Depigmenting Ointment for Melasma

CTR20192306Phase 2Completed

Sponsor
Hangzhou Qianjin Pharmaceutical Co., Ltd.
Start
Nov 2019
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Yuhudie Melasma Ointment in melasma, sponsored by Hangzhou Qianjin Pharmaceutical Co., Ltd.. Started Nov 2019; status: completed.

02

Drugs

Yuhudie Melasma Ointment
03

Conditions

melasma

Beyond the preview

Go deeper on CTR20192306.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20192306.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call